Lymphoid neogenesis in murine cardiac allografts undergoing chronic rejection

American Journal of Transplantation

Volumn 5, Issue 3, 2005, Pages 510-516

  Baddoura, Fady K ^a   Nasr, Isam W ^b   Wrobel, Barbara ^a   Li, Qi ^b   Ruddle, Nancy H ^b   Lakkis, Fadi G ^b  

^a UNIVERSITY AT BUFFALO   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Allograft rejection; Lumphoid neogenesis; PNAd; Tertiary lymphoid organs; Transplantation

Indexed keywords

ADDRESSIN; PERIPHERAL NODE ADDRESSIN; UNCLASSIFIED DRUG;

ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN PRESENTATION; ARTICLE; AUTOIMMUNITY; B LYMPHOCYTE; CARDIAC GRAFT REJECTION; CHRONIC GRAFT REJECTION; CONTROLLED STUDY; CORRELATION ANALYSIS; HEART TRANSPLANTATION; LYMPHOID TISSUE; MOUSE; NONHUMAN; PREVALENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RETROSPECTIVE STUDY; T LYMPHOCYTE ACTIVATION;

ANIMALS; CHRONIC DISEASE; GRAFT REJECTION; HEART TRANSPLANTATION; LYMPHOID TISSUE; MICE; MYOCARDIUM; TRANSPLANTATION, HOMOLOGOUS;

EID: 14644435067     PISSN: 16006135     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2004.00714.x     Document Type: Article

References (21)

1. Ruddle N. Lymphoid neo-organogenesis: Lymphotoxin's role in inflammation and development. Immunol Res 1999; 19: 119-125.
2. Hjelmstrom P. Lymphoid neogenesis: De novo formation of lymphoid tissue in chronic inflammation through expression of homing chemokines. J Leukoc Biol 2001; 69: 331-339.
3. Weyand C, Kurtin P, Goronzy J. Ectopic lymphoid organogenesis: A fast track for autoimmunity. Am J Pathol 2001; 159: 787-793.
4. Drayton D, Ying X, Lee J, Lesslauer W, Ruddle N. Ectopic LTab directs lymphoid organ neogenesis with concomitant expression of peripheral node addressin and a HEV-restricted sulfotransferase. J Exp Med 2003; 197: 1153-1163.
5. Girard J, Springer High endothelial venules (HEVs): Specialized endothelium for lymphocyte migration. Immunol Today 1995; 16: 449-457.
6. Kratz A, Campos-Neto A, Hanson M, Ruddle N. Chronic inflammation caused by lymphotoxin is lymphoid neogenesis. J Exp Med 1996; 183: 1461-1472.
7. Schrama D, thor Straten P, Fischer W et al. Targeting lymphotoxin-a to the tumor elicits an efficient immune response associated with induction of peripheral lymphoid-like tissue. Immunity 2001; 14: 111-121.
8. Yu P, Lee Y, Liu W et al. Priming of naive T cells inside tumors leads to eradication of established tumors. Nat Immunol 2004; 5: 141-149.
9. Toppila S, Paavonen T, Nieminen M, Hayry P, Renkonen R. Endothelial L-selectin ligands are likely to recruit lymphocytes into rejecting heart transplants. Am J Pathol 1999; 155: 1303-1310.
10. Kirveskari J, Paavonen T, Hayry P, Renkonen R. De novo induction of endothelial L-selectin ligands during kidney allograft rejection. J Am Soc Nephrol 2000; 11: 2358-2365.
11. Corry RJ, Winn HJ, Russel PS. Primarily vascularized allografts of hearts in mice: The role of H-2D, H-2K, and non H-2 antigens. Transplantation 1973; 16: 343-350.
12. Billingham ME, Gary NRB, Hammond ME et al. A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection: Heart rejection study group. J Heart Transplant 1990; 9: 587-593.
13. Chalasani G, Li Q, Konieczny B et al. The allograft defines the type of rejection (acute versus chronic) in the face of an established effector immune response. J Immunol 2004; 172: 7813-7820.
14. Hemmerich S, Butcher E, Rosen S. Sulfation-dependent recognition of high endothelial venules (HEV)-ligands by L-selectin and MECA 79, an adhesion- blocking monoclonal antibody. J Exp Med 1994; 180: 2219-2226.
15. Rosen S. Endothelial ligands for L-selectin: from lymphocyte recirculation to allograft rejection. Am J Path 1999; 155: 1013-1020.
16. Hemmerich S, Bistrup A, Singer M et al. Sulfation of L-selectin ligands by an HEV-restricted sulfotransferase regulates lymphocyte homing to lymph nodes. Immunity 2001; 15: 237-247.
17. Libby P, Pober JS. Chronic rejection. Immunity 2001; 14: 387-397.
18. Vella P, Spadafora-Ferreira M, Murphy B et al. Indirect allorecognition of major histocompatibility complex allopeptides in human renal transplant recipients with chronic graft dysfunction. Transplantation 1997; 64: 795-800.
19. Ciubotariu R, Liu Z, Colovai AI et al. Persistent allopeptide reactivity and epitope spreading in chronic rejection of organ allografts. J Clin Invest 1998; 101: 398-405.
20. Mebius R. Organogenesis of lymphoid tissues. Nature Rev Immunol 2003; 3: 292-303.
21. Kurkijarvi R, Jalkanen S, Isoniemi H, Salmi M. Vascular adhesion protein-1 (VAP-1) mediates lymphocyte-endothelial interactions in chronic kidney rejection. Eur J Immunol 2001; 31: 2876-2884.